Case for More Autologous Transplants in Myeloma in Resource-Constrained Settings-Reference-Cited by-同舟云学术

Case for More Autologous Transplants in Myeloma in Resource-Constrained Settings

Published:2022-06 Issue:03 Volume:43 Page:311-313
ISSN:0971-5851
Container-title:Indian Journal of Medical and Paediatric Oncology
language:en
Short-container-title:Indian J Med Paediatr Oncol

Author:

Singh Suvir¹^ORCID,Sharma Rintu¹

Affiliation:

1. Department of Clinical Hematology and Stem Cell Transplantation, Dayanand Medical College, Ludhiana, Punjab, India

Abstract

AbstractMultiple myeloma is characterized by a near universal risk of relapse. Autologous stem cell transplantation provides a significant progression free survival benefit but is under utilized worldwide. We provide a small snapshot of why ASCT assumes greater importance in resource-constrained settings.

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1743504.pdf

Reference19 articles.

1. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003;S Y Kristinsson;J Clin Oncol,2007

2. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population-based study;Y Usui;Int J Cancer,2020

3. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up†;M A Dimopoulos;Ann Oncol,2021

4. Optimizing outcomes for patients with newly diagnosed multiple myeloma eligible for transplantation;P Moreau;Leuk Suppl,2013

5. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial;M-V Mateos;Lancet,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24

2. The poignant paradox of treating multiple myeloma in young patients;Cancer Research, Statistics, and Treatment;2023